Evaluation of Hemodynamic Parameters Following Transjugular Intrahepatic Portosystemic Shunt (TIPS)
NCT04050683 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2024-12-13
Summary
During a TIPS procedure, a shunt or stent (mesh tube) is passed down the jugular vein (the vein above the collarbone in the neck) using fluoroscopy (real time x-rays) guidance. Then, a stent is inserted between the portal vein (vein that carries blood from the intestines into the liver) to a hepatic vein (vein that carries blood away from the liver back to the heart). This means that blood that would usually gets filtered through the liver is now bypassing the liver and going directly to the heart. Because more blood will be flowing to the heart, the heart needs to be strong enough to handle the extra volume.
This study is being done to determine the impact of the TIPS procedure on cardiac (heart) function by collecting data (heart pressures) during the TIPS procedure. Immediately after TIPS and at standard follow-up time points, labs and transthoracic echocardiograms (TTE or echo) will also be collected.
The device(s) used in this study are neither the intervention studied nor the experimental variable of interest. Devices are commercially available and used, and procedures are performed, in accordance with the institution's standard of care.
Conditions
- Refractory Ascites
Interventions
- PROCEDURE
-
Study - Transjugular Intrahepatic Portosystemic Shunt (TIPS)
Prior to and 1-3 days after the TIPS procedure, the following blood tests are done for research purposes: Brain Natriuretic Peptide (BNP); Endothelin-1; Tumor Necrosis Factor-alpha (TNF-a); Endothelial Nitric Oxide Synthase (eNOS). Subjects with abnormal heart pressures during TIPS will have a right heart catheterization (RHC) to monitor heart function, blood flow, and pressures in and around the heart. The subject will be admitted to the Cardiovascular Intensive Care Unit and have a TTE all of which are standard of care. Routine follow-up visits will occur in IR Clinic at 2 Weeks (± 3 days), 4-6 weeks and 4-6 months. Visits will include: blood draws for research related blood tests as listed above; standard of care ultrasound of the abdomen; TTEs; and for at least one year, routine lab testing, imaging, medications, and subject overall condition will be assessed for long term outcomes. Diagnostic RHC will be done as needed per standard of care.
- PROCEDURE
-
Control - Transjugular Intrahepatic Portosystemic Shunt (TIPS)
Subject's with normal heart pressures who are having elective (planned in advance and not due to an emergency) TIPS due to refractory ascites (fluid build up in the belly that does not go away or comes back shortly after being removed). Prior to and 1-3 days after the TIPS procedure, the following blood tests are done for research purposes: Brain Natriuretic Peptide (BNP); Endothelin-1; Tumor Necrosis Factor-alpha (TNF-a); Endothelial Nitric Oxide Synthase (eNOS). The subject will be admitted to the hospital after TIPS for standard of care monitoring. Routine follow-up visits will occur in IR Clinic at 2 Weeks (± 3 days), 4-6 weeks and 4-6 months. Visits will include: blood draws for research related blood tests as listed above; standard of care ultrasound of the abdomen; and for at least one year, routine lab testing, imaging, medications, and subject overall condition will be assessed for long term outcomes.
Sponsors & Collaborators
-
Radiological Society of North America
collaborator OTHER -
Medical College of Wisconsin
lead OTHER
Principal Investigators
-
Eric J Hohenwalter, MD · Medical College of Wisconsin
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-09-25
- Primary Completion
- 2024-12-09
- Completion
- 2024-12-09
Countries
- United States
Study Locations
More Related Trials
-
Preemptive TIPS for Variceal Bleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis
NCT06122753 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Prevention of Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis
NCT01326949 ·Status: COMPLETED ·Phase: NA
-
TIPS With Coated Stents for Refractory Ascites in Patients With Cirrhosis
NCT00222014 ·Status: COMPLETED ·Phase: NA
-
Comparison of Underdilated Versus Standard TIPS in Preventing Variceal Rebleeding in Patients With Cirrhosis
NCT07253389 ·Status: RECRUITING ·Phase: NA
-
Early Use of TIPSS in Patients With Cirrhosis and Variceal Bleeding
NCT02377141 ·Status: COMPLETED ·Phase: NA
-
The Impact of Transjugular Intrahepatic Portosystemic Shunt on Recompensation in Patients With Decompensated Liver Cirrhosis
NCT07172035 ·Status: RECRUITING
-
Clinical Course of Cirrhotic Patients With Portal Vein Thrombosis Treated With TIPS
NCT03031717 ·Status: UNKNOWN
-
TIPS Combined With Variceal Embolization for the Prevention of Variceal Rebleeding in Patients With Cirrhosis
NCT02119988 ·Status: COMPLETED ·Phase: NA
-
Small Diameter TIPS in Patients with Severe Liver Atrophy and Variceal Bleeding
NCT06589531 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Preemptive TIPS for Gastric Variceal Bleeding in Patients With Cirrhosis
NCT06122792 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Band Ligation Versus Transjugular Intrahepatic Portosystemic Stent Shunt (TIPS) in Cirrhotics With Recurrent Variceal Bleeding Non Responding to Medical Therapy
NCT00570973 ·Status: COMPLETED ·Phase: PHASE4
-
TIPS for Variceal Rebleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis and CTPV
NCT02853526 ·Status: UNKNOWN ·Phase: PHASE3
-
The Influence of Post-transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy
NCT03825848 ·Status: UNKNOWN ·Phase: NA
-
Embolization of Large Spontaneous Portosystemic Shunts for the Prevention of Post-TIPS Hepatic Encephalopathy
NCT02156232 ·Status: COMPLETED ·Phase: NA
-
TIPS in Patients With Decompensated Liver Cirrhosis
NCT04801290 ·Status: RECRUITING
-
Low Molecular Weight Heparin for the Prevention of Early TIPS Dysfunction
NCT03171727 ·Status: UNKNOWN ·Phase: NA
-
Non-invasive Evaluation Program for TIPS and Follow Up Network 2 (NEPTUN2)
NCT04393519 ·Status: RECRUITING
-
Freiburg TIPS Registry
NCT05782556 ·Status: RECRUITING
-
To Study the Efficacy and Safety of TIPS (Trans Intrahepatic Portosystemic Shunt) Versus Self Expanding Metallic Stent (SEMS) in the Management of Refractory Variceal Bleed in Cirrhotics.
NCT03827681 ·Status: UNKNOWN ·Phase: NA
-
Magnetic Resonance Technics for the Assessment of Liver Function Before and After TIPS
NCT03933891 ·Status: UNKNOWN
-
Early TIPS With Polytetrafluoroethylene (PTFE) Covered Stents for Acute Variceal Bleeding in Patients With Advanced Cirrhosis
NCT01370161 ·Status: COMPLETED ·Phase: NA
-
Effect of Transjugular Intrahepatic Portosystemic Shunt on Oxygenation in Cirrhotic Patients With Hepatopulmonary Syndrome
NCT02148536 ·Status: COMPLETED
-
TIPS vs Endoscopic Therapy for Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis
NCT02485184 ·Status: UNKNOWN ·Phase: NA
-
TIPS for PH Patients: an Observational, Cohort Study
NCT06221982 ·Status: RECRUITING
-
ALTA TIPS: A 5-year Longitudinal Observational Study of Patients Undergoing TIPS Placement
NCT03973372 ·Status: ACTIVE_NOT_RECRUITING